The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, September 17, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 16, 2025 the Company sold 7 735 (seven thousand seven hundred and thirty-five) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 20 547.75 on the Bulgarian Stock Exchange, the average price per share was BGN 2.66.
Sofia, Bulgaria, September 16, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 15, 2025 the Company sold 2071 (two thousand and seventy-one) treasury shares representing 0.0004% of the share capital of the Company, at a total value of BGN 5 591.70 on the Bulgarian Stock Exchange, the average price per share was BGN 2.70.
Sofia, Bulgaria, September 15, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 12, 2025 the Company sold 20 950 (twenty thousand nine hundred and fifty) treasury shares representing 0.004% of the share capital of the Company, at a total value of BGN 56 246.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.68.
